Cargando…
Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus
SIMPLE SUMMARY: The detection of genetic alterations in cancer is important to obtain knowledge of the underlying mutational tumor composition. Knowing the mutational profile can assist oncologists on tailoring optimal personalized treatments. Moreover, obtaining additional information from a broade...
Autores principales: | Vestergaard, Lau K., Oliveira, Douglas N. P., Poulsen, Tim S., Høgdall, Claus K., Høgdall, Estrid V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533843/ https://www.ncbi.nlm.nih.gov/pubmed/34680378 http://dx.doi.org/10.3390/cancers13205230 |
Ejemplares similares
-
Genetic profiling of somatic alterations by Oncomine Focus Assay in Korean patients with advanced gastric cancer
por: Park, Joonhong, et al.
Publicado: (2020) -
Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations
por: Cho, Yong Gon, et al.
Publicado: (2023) -
Next Generation Sequencing Technology in the Clinic and Its Challenges
por: Vestergaard, Lau K., et al.
Publicado: (2021) -
Performance Characteristics of Oncomine Focus Assay for Theranostic Analysis of Solid Tumors, A (21-Months) Real-Life Study
por: Bamba-Funck, Jessica, et al.
Publicado: (2023) -
Potential Targeted Therapies in Ovarian Cancer
por: Sisman, Yagmur, et al.
Publicado: (2022)